Author:
Butterworth Roger F.,McPhail Mark J. W.
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Delcker AM, Jalan R, Schumacher M, Comes G. l-Ornithine l-aspartate versus placebo in the treatment of hepatic encephalopathy: a meta-analysis of randomised placebo-controlled trials using individual data. Hepatology. 2000;4:604 (abstract).
2. Jiang Q, Jiang XH, Zheng MH, Chen YP. l-Ornithine l-aspartate in the management of hepatic encephalopathy: a meta-analysis. J Gastroenterol Hepatol. 2009;24:9–14.
3. Bai M, Yang Z, Qi X, Fan D, Han G. l-Ornithine l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2013;28:783–92.
4. Goh ET, Stokes CS, Vilstrup H, Gluud LL, Morgan MY. l-Ornithine l-aspartate for hepatic encephalopathy: a systematic review with meta-analysis of randomised controlled trials. J Hepatol. 2017;66:131 (abstract).
5. Butterworth RF, Kircheis G, Hilger N, McPhail MJW. Efficacy of l-ornithine l-aspartate for the treatment of hepatic encephalopathy and hyperammonemia in cirrhosis: systematic review and meta-analysis of randomized controlled trials. J Clin Exp Hepatol. 2018;8:301–3.
https://doi.org/10.1016/j.jceh.2018.05.004
.
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献